1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="P1">The sulfation at the 3-OH position of glucosamine is an important modification in forming structural domains for heparan sulfate to enable its biological functions. Seven 3- <i>O</i>-sulfotransferase isoforms in the human genome are involved in the biosynthesis of 3- <i>O</i>-sulfated heparan sulfate. As a rare modification present in heparan sulfate, the availability of 3- <i>O</i>-sulfated oligosaccharides is very limited. Here, we report the use of a chemoenzymatic synthetic approach to synthesize six 3- <i>O</i>-sulfated oligosaccharides, including three hexasaccharides and three octasaccharides. The synthesis was achieved by rearranging the enzymatic modification sequence to accommodate the substrate specificity of 3- <i>O</i>-sulfotransferase 3. We studied the impact of 3- <i>O</i>-sulfation on the conformation of the pyranose ring of 2- <i>O</i>-sulfated iduronic acid using NMR, and on the correlation between ring conformation and anticoagulant activity. We identified a novel octasaccharide that interacts with antithrombin and displays anti factor Xa activity. Interestingly, the octasaccharide displays a faster clearance rate than fondaparinux, an FDA approved pentasaccharide drug, in a rat model, making this octasaccharide a potential short acting anticoagulant drug candidate that could reduce bleeding risk. Having access to a set of critically important 3- <i>O</i>-sulfated oligosaccharides offers the potential to develop new heparan sulfate-based therapeutics. </p><p id="P2"> <div class="figure-container so-text-align-c"> <img alt="" class="figure" src="/document_file/6e80e757-f52b-4185-abd4-af61874be210/PubMedCentral/image/nihms864307u1.jpg"/> </div> </p>

          Related collections

          Author and article information

          Journal
          Journal of the American Chemical Society
          J. Am. Chem. Soc.
          American Chemical Society (ACS)
          0002-7863
          1520-5126
          March 31 2017
          April 12 2017
          April 03 2017
          April 12 2017
          : 139
          : 14
          : 5249-5256
          Affiliations
          [1 ]Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States
          [2 ]National Glycoengineering Research Center, Shandong University, Jinan 250100, China
          [3 ]Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602, United States
          [4 ]School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, United Kingdom
          [5 ]Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, United States
          Article
          10.1021/jacs.7b01923
          5624809
          28340300
          aca008f3-c433-43a5-a260-0f3c6fbc0731
          © 2017
          History

          Comments

          Comment on this article